ml-si3 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
ml-si3
Ml Si3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ml+si3/ML-SI3/custom%40hy-139426%4010%2E64898%2F2026%2E06%2E26%2E734916
Average 94 stars, based on 17 article reviews
Ml Si3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ml+si3/ML-SI3/custom%40hy-139426%4010%2E64898%2F2026%2E06%2E26%2E734916
Average 94 stars, based on 17 article reviews
ml-si3 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Live Cell Imaging:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Transfection:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Fluorescence:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Expressing:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Translocation Assay:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Staining:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Comparison:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Whisker Assay:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Control:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Patch Clamp:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Isolation:Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), Article Title: MONNA alleviates MPTP-induced Parkinson's disease in zebrafish by activating TFEB dependently on ER Calcium. Article Snippet: A-synuclein aggregation is a biomarker of Parkinson’s disease (PD) whose feature is the progressive loss of dopaminergic neuron in the middle brain.. The removal of a-synuclein aggregation through autophagy-lysosome pathway is a promising strategy for PD treatment.. Transcription factor EB (TFEB) is a master regulator of autophagic and lysosomal biogenesis and function. Article Title: Ca 2+ and DRP1 drive endocytic lysosome reformation at tripartite contact sites Article Snippet: The following reagents were used in this study: Article Title: Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation Article Snippet: Cells were propagated in a humidified incubator at 37°C and 5% CO 2 , using RPMI 1640 medium prepared with 10% fetal bovine serum (Sigma, St. Louis, MO), and treated as specified with vacuolin‐1 (673000, Sigma), ionomycin (407951, Sigma), Article Title: Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity Article Snippet: MnTBAP (HY-126397), Fluo-4 (HY-101896), ML-SI3 (HY-139426), 2-APB (HY-W009724), and Article Title: TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells. Article Snippet: For cellular treatments the following reagents were used: Torin 1 (Tocris, 4247), Mitomycin C (Merck (Roche), 10107409001), ML-SA1 (Bio-Techne, 4746), ML-SA5 (Enamine Ltd., 2418670-70-7), Bafilomycin A (Sigma, B1793), |
